We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$71.2B
Turnover
9.3%
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter
Est. Return
+11.68%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
–
AUM
$51B
AUM Growth
+$4.88B
(+11%)
Cap. Flow
+$834M
Cap. Flow
% of AUM
1.63%
Top 10 Holdings %
Top 10 Hldgs %
25.68%
Holding
986
New
26
Increased
432
Reduced
416
Closed
39
Avg Time Held
4.6
years
Top 10 Avg Time Held
3.2
years
Top 20 Avg Time Held
2.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kaspi.kz JSC
KSPI
|
+$260M |
| 2 |
Microsoft
MSFT
|
+$71.2M |
| 3 |
Cardinal Health
CAH
|
+$61.4M |
| 4 |
Clorox
CLX
|
+$47.7M |
| 5 |
Accenture
ACN
|
+$46.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sociedad Química y Minera de Chile
SQM
|
+$63.6M |
| 2 |
Splunk Inc
SPLK
|
+$56.2M |
| 3 |
L3Harris
LHX
|
+$46.8M |
| 4 |
Crown Holdings
CCK
|
+$43M |
| 5 |
Fomento Económico Mexicano
FMX
|
+$38.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.39% |
| 2 | Healthcare | 17.34% |
| 3 | Financials | 11.02% |
| 4 | Consumer Discretionary | 9.2% |
| 5 | Industrials | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
726
Huazhu Hotels Group
HTHT
$14.7B
| $3.31M | 0.01% |
85,494
-3,632
| -4% | -$126K |
2021 Q3
10 quarters
|
|
727
BeOne Medicines Ltd
ONC
$41.8B
| $3.31M | 0.01% |
21,138
| – | – |
2018 Q4
21 quarters
|
|
728
Adaptive Biotechnologies
ADPT
$3.84B
| $3.3M | 0.01% |
1,029,447
+95,653
| +10% | +$370K |
2023 Q4
1 quarter
|
|
|
RNAM
729
DELISTED
Avidity Biosciences
RNAM
| $3.3M | 0.01% |
129,414
| – | – |
2023 Q4
1 quarter
|
|
730
IHS Holding
IHS
$2.86B
| $3.24M | 0.01% |
916,700
+471,817
| +106% | +$1.61M |
2022 Q3
6 quarters
|
|
731
Rallybio
RLYB
$88.4M
| $3.2M | 0.01% |
215,883
| – | – |
2023 Q4
1 quarter
|
|
732
UiPath
PATH
$6.69B
| $3.19M | 0.01% |
140,824
+3,820
| +3% | +$89.4K |
2021 Q2
11 quarters
|
|
733
Nordson
NDSN
$17.9B
| $3.17M | 0.01% |
11,563
-139
| -1% | -$36.2K |
2020 Q2
15 quarters
|
|
734
The GEO Group
GEO
$3.77B
| $3.14M | 0.01% |
222,700
| – | – |
2018 Q2
23 quarters
|
|
735
Lear
LEA
$5.92B
| $3.12M | 0.01% |
21,566
-866
| -4% | -$119K |
2017 Q3
26 quarters
|
|
736
Generac Holdings
GNRC
$11.4B
| $3.09M | 0.01% |
24,487
-376
| -2% | -$44.1K |
2019 Q4
17 quarters
|
|
737
Pyxis Oncology
PYXS
$142M
| $3.02M | 0.01% |
708,303
| – | – |
2023 Q4
1 quarter
|
|
738
Autoliv
ALV
$8.35B
| $3.01M | 0.01% |
24,968
-65
| -0.3% | -$7.27K |
2017 Q3
26 quarters
|
|
739
Scholar Rock
SRRK
$4.86B
| $3M | 0.01% |
168,997
| – | – |
2023 Q4
1 quarter
|
|
740
Bio-Rad Laboratories Class A
BIO
$9.46B
| $3M | 0.01% |
8,663
-129
| -1% | -$42.4K |
2019 Q4
17 quarters
|
|
741
HEICO Corp
HEI
$43.3B
| $2.95M | 0.01% |
15,453
-46
| -0.3% | -$8.54K |
2019 Q2
19 quarters
|
|
742
Tencent Music
TME
$14.1B
| $2.86M | 0.01% |
255,276
-831
| -0.3% | -$8.15K |
2020 Q1
16 quarters
|
|
743
Mirum Pharmaceuticals
MIRM
$5.21B
| $2.76M | 0.01% |
+109,758
| New | +$3.02M |
2024 Q1
0 quarters
|
|
744
AES
AES
$10.7B
| $2.73M | 0.01% |
152,049
-4,281
| -3% | -$71.5K |
2017 Q3
26 quarters
|
|
745
Unity
U
$17.8B
| $2.72M | 0.01% |
101,743
+1,816
| +2% | +$57.1K |
2021 Q2
11 quarters
|
|
746
Mereo BioPharma
MREO
$49.3M
| $2.7M | 0.01% |
817,309
-733,773
| -47% | -$2.48M |
2023 Q4
1 quarter
|
|
747
SEI Investments
SEIC
$12.5B
| $2.69M | 0.01% |
37,422
+499
| +1% | +$33.1K |
2017 Q4
25 quarters
|
|
748
Southwest Airlines
LUV
$19.3B
| $2.68M | 0.01% |
91,927
-3,984
| -4% | -$123K |
2017 Q3
26 quarters
|
|
749
Tarsus Pharmaceuticals
TARS
$3.18B
| $2.62M | 0.01% |
72,032
| – | – |
2023 Q4
1 quarter
|
|
750
Zillow
Z
$6.93B
| $2.59M | 0.01% |
53,039
-149
| -0.3% | -$8.11K |
2018 Q2
23 quarters
|
|
Similar funds
Aberdeen Group's Q1 2024 Portfolio in Review
As of Q1 2024, Aberdeen Group held 986 positions worth $51B, up 11% from $46.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Aberdeen Group's Q1 2024 filing shows 26 new, 432 increased, 416 reduced and 39 closed positions. Its largest new stake was Kaspi.kz JSC: 2,541,596 shares worth $327M. The largest sale was Sociedad Química y Minera de Chile, an estimated $63.6M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- Aberdeen Group's largest Q1 2024 buy was Kaspi.kz JSC: 2,541,596 shares worth $327M.
- Aberdeen Group added most to Microsoft in Q1 2024, an estimated $71.2M increase.
- Aberdeen Group's biggest Q1 2024 reduction was Sociedad Química y Minera de Chile, cutting an estimated $63.6M.
- Aberdeen Group fully exited Splunk Inc in Q1 2024, selling an estimated $56.2M.
- Aberdeen Group's ten largest holdings make up 26% of its $51B portfolio in Q1 2024.
- Aberdeen Group opened 26 new positions and closed 39 in Q1 2024.
- Aberdeen Group's portfolio value rose 11% quarter-over-quarter to $51B.
Based on Aberdeen Group's 13F filing for Q1 2024, filed 9 May 2024.